PRRT2 and B-cell chronic lymphocytic leukemia: Since stromal PKC upregulation was evidenced in various haematological malignancies including chronic lymphoid leukaemia (CLL), acute lymphoid leukaemia (ALL) and mantle cell lymphoma, the authors suggested that this pathway could be a common mechanism of survival in haematological malignancies [16].